BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CPCS Website - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.publiccounsel.net
X-WR-CALDESC:Events for CPCS Website
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230428T073000
DTEND;TZID=UTC:20230430T173000
DTSTAMP:20260501T183210
CREATED:20230729T223745Z
LAST-MODIFIED:20230729T223745Z
UID:10000746-1682667000-1682875800@www.publiccounsel.net
SUMMARY:Psychopharmacology 2023: A Master Class
DESCRIPTION:We are pleased to offer our 13th annual two-day course uniquely designed for practicing clinicians\, clinical researchers and trainees in psychiatry. Presentations will focus on typical psychiatric patients with emphasis on those who are difficult to treat or are treatment resistant. Newer treatments and developing treatment strategies will be discussed including the use of genetic tests\, blood level measurements and drug combinations. There will be considerable opportunity for interaction with the presenters.\nThis conference will focus on the following topics: An updated review of neurobiology and brain function taking the attendee through neurotransmission sequence from the central role of neurotransmitter circuits\, transmitters and receptors\, synaptic function and gene transcription. Interaction between genes and the environment. Drug treatment of schizophrenia and bipolar disorder will be presented with a focus on prodromal symptoms and first episode patients\, as well as long-term maintenance and treatment resistant patients. New antipsychotic medications and treatment augmentation will be reviewed along with potential new uses for mood stabilizers. Neurobiological mechanisms of depression with a discussion of both the genetic and epigenetic contribution as well as the role of inflammation will be highlighted. Modern use of antidepressants will be based on the latest clinical findings. Special consideration will be given to ketamine\, ECT\, TMS\, psychedelics and augmentation strategies for treatment resistant depression and bipolar depression. Diagnosis and treatment of of Anxiety\, Borderline Personality Disorder\, OCD and eating disorder patients will be presented\, along with a discussion of the risks and benefits of benzodiazepines. The etiology and treatment of PTSD will be discussed. Special consideration will be given to use of blood levels and dosing and innovative combinations in the treatment of resistant psychiatric disorders. The importance of the evaluation and psychopharmacological treatment of women’s mental health issues will be addressed with particular emphasis on PMS\, perinatal and postpartum disorders. The course will also include a review of the neurobiology and treatment of sleep disorders in psychiatry as well as a lecture on the neurobiology and treatment of alcohol\, cannabis and other substance abuse disorders. Latest advances in geriatric psychopharmacology will be reviewed. \nAnxiety and anxiety-spectrum disorders as well as their pharmacological treatment will be presented\, including panic disorder\, social anxiety disorder and generalized anxiety disorder. New concepts and treatments of obsessive compulsive disorder will be reviewed as well as the pharmacological treatment of borderline personality disorder. The importance of the evaluation and psychopharmacological treatment of women’s mental health issues will be addressed with particular emphasis on PMS\, perinatal and postpartum disorders and treatment resistant PTSD. The course will also include a review of the role of psychopharmacology in the treatment of sleep disorders. Advances in the neurobiology and treatment of alcohol and substance abuse disorders will also be highlighted. The latest advances in child\, adolescent and geriatric psychopharmacology will be emphasized. Throughout the course the establishment and importance of the therapeutic alliance when prescribing all psychotropic medications will be underscored\, as will the potential hazards/benefits of polypharmacy drug interactions. \nPsychopharmacology 2023: A Master Class – Agenda\n4.5 CAFL CLEs \nFor more information please visit: https://cmecatalog.hms.harvard.edu/psychopharmacology-master-class \n\n\n\nQuestions?\nPlease contact the Continuing Education Programs with any questions and to register by email at ceprograms@hms.harvard.edu or phone at (617) 384-8600. 
URL:https://www.publiccounsel.net/event/psychopharmacology-2023-a-master-class/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230428T090000
DTEND;TZID=UTC:20230428T123000
DTSTAMP:20260501T183210
CREATED:20230729T222745Z
LAST-MODIFIED:20230729T222745Z
UID:10000698-1682672400-1682685000@www.publiccounsel.net
SUMMARY:MHLD Appellate Certification Training
DESCRIPTION:Application and further details to be posted at a later date.  For questions contact Karen Talley at ktalley@localhost/cpcs
URL:https://www.publiccounsel.net/event/mhld-appellate-certification-training-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230428T090000
DTEND;TZID=UTC:20230428T170000
DTSTAMP:20260501T183210
CREATED:20230729T222146Z
LAST-MODIFIED:20230729T222146Z
UID:10000670-1682672400-1682701200@www.publiccounsel.net
SUMMARY:Storytelling Program Day 2
DESCRIPTION:Storytelling Program day 2 of 3.  You must submit an application to participate in this program.  Application Deadline February 15\, 2023\ncontact Kristen Munichiello for details: kmunichiello@localhost/cpcs
URL:https://www.publiccounsel.net/event/storytelling-program-day-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230428T090000
DTEND;TZID=UTC:20230428T170000
DTSTAMP:20260501T183210
CREATED:20230729T223746Z
LAST-MODIFIED:20230729T223746Z
UID:10000747-1682672400-1682701200@www.publiccounsel.net
SUMMARY:Minding the Gap: Gender and the Mental Health Crisis
DESCRIPTION:This program is hosted by Harvard Radcliffe Institute. Any questions or issues regarding this program should be directed there (info@radcliffe.harvard.edu). This event is being listed for informational purposes only. CPCS staff cannot assist with\, or solve\, registration issues.\nThis is a free event with options for both live and virtual attendance. \nThis program qualifies for 6 CLE on the CPCS Mental Health Panel and Mental Health Appeals Panel \nfor more information and to register please use link below: \nhttps://www.radcliffe.harvard.edu/event/2023-minding-the-gap-conference
URL:https://www.publiccounsel.net/event/minding-the-gap-gender-and-the-mental-health-crisis/
CATEGORIES:In-Person|Private Counsel|Public|Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230428T130000
DTEND;TZID=UTC:20230428T140000
DTSTAMP:20260501T183210
CREATED:20230729T223945Z
LAST-MODIFIED:20230729T223945Z
UID:10000756-1682686800-1682690400@www.publiccounsel.net
SUMMARY:Monthly CAFL Race Equity Drop-In!
DESCRIPTION:Have you ever witnessed or experienced implicit bias or racism in your CAFL casework and didn’t know how to respond in the moment? Do you feel like you could use some ideas on how to respond if this happens to you? Come brainstorm with colleagues in a no-judgment and no-pressure environment on how to respond to these incidents when they occur and beyond! Join us for the next Racial Equity Drop-In on April 28\, 2023 from 1-2PM. We look forward to seeing those who can come and to continuing the great\, substantive\, creative conversations we are having at these drop-ins.\nApproved for 1 CAFL CLE. \nRegister here!
URL:https://www.publiccounsel.net/event/monthly-cafl-race-equity-drop-in-3/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230428T130000
DTEND;TZID=UTC:20230428T143000
DTSTAMP:20260501T183210
CREATED:20230729T223945Z
LAST-MODIFIED:20230729T223945Z
UID:10000755-1682686800-1682692200@www.publiccounsel.net
SUMMARY:SAMHSA Presents: Advancing an Alternative: Peer-led\, Community-Based Services that Promote Equity and Safety for All
DESCRIPTION:This program is hosted by Bazelton Center for Mental Health Law and by SAMHSA. Any questions or issues regarding this program should be directed there:  Kelle Masten via email at kelle.masten@nasmhpd.org or Paige Thomas at paige.thomas@nasmhpd.org.  This event is being listed for informational purposes only. CPCS staff cannot assist with\, or solve\, registration issues.\nTHIS PROGRAM QUALIFIES FOR 1.5 CLE ON THE MENTAL HEALTH AND MENTAL HEALTH APPEALS PANELS \nDescription: \nThis webinar is part 2 of a 2-webinar Learning Community hosted by the Bazelon Center for Mental Health Law and National Disability Rights Network (NDRN) that addresses SAMHSA’s priorities of crisis stabilization\, mobile crisis\, and children. The learning community will focus on leveraging federal funding & policy to increase best practice community-based services that are voluntary\, evidence-based\, and trauma-informed. \nLearning Objectives: \nBy the end of this workshop\, participants will be able to: 1. Understand the disproportionate negative impacts of traditional crisis response systems on over reliance on the police to respond to crises involving communities and people with disabilities\, including people with serious mental illness (SMI) or emotional disturbance (SED)\, and how solutions must be responsive to these disparities. 2. Learn how peer-led\, community-based services and supports improve wellness\, support communities\, and protect civil rights\, drawing from real-world examples of programs that have been successfully implemented. 3. Examine current trends in state and federal policy\, including challenges and opportunities to advance peer-led\, community-based services for people with SMI or SED. \nThis is a SAMHSA-Sponsored webinar. \nLive closed captioning and ASL interpreters will be available for this webinar. \nREGISTER HERE
URL:https://www.publiccounsel.net/event/samhsa-presents-advancing-an-alternative-peer-led-community-based-services-that-promote-equity-and-safety-for-all/
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR